Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children ‡¨ù the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1096 Study Group 1